Hereditary paragangliomas

Advances in Oto-Rhino-Laryngology

Volumn 70, Issue , 2011, Pages 99-106

  Raygada, Margarita ^a   Pasini, Barbara ^c   Stratakis, Constantine A ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SUCCINATE DEHYDROGENASE;

ARTICLE; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HUMAN; MUTATION; NEUROFIBROMATOSIS; PARAGANGLIOMA; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; SIPPLE SYNDROME; SYNDROME; VON HIPPEL LINDAU DISEASE;

GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GERM-LINE MUTATION; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; NEUROFIBROMATOSIS 1; PARAGANGLIOMA; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; SUCCINATE DEHYDROGENASE; SYNDROME; VON HIPPEL-LINDAU DISEASE;

EID: 79952392876     PISSN: 00653071     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000322484     Document Type: Article

References (39)

1. Winship T, Kloop CT, Jenkins WH: Glomus Jugularis Tumors. Cancer 1948;1:441.
2. Parry DM, Li FP, Strong LC, Carney JA, Schottenfeld D, Reimer RR, Grufferman S: Carotid body tumors in humans: genetics and epidemiology. J Natl Cancer Inst 1982;68:573-578. (Pubitemid 12078840)
3. Grufferman S, Gillman MW, Pasternak LR, Peterson CL, Young WG Jr: Familial carotid body tumors: case report and epidemiologic review. Cancer 1980;46:2116-2122. (Pubitemid 10025492)
4. van der Mey AG, Maaswinkel- Mooy PD, Cornelisse CJ, Schmidt PH, Van De Kamp JJ: Genomic imprinting in hereditary glomus tumours: evidence for new genetic theory. Lancet 1989;ii:1291-1294. (Pubitemid 20005669)
5. Sobol SM, Dailey JC: Familial multiple cervical paragangliomas: report of a kindred and review of the literature. Otolaryngol Head Neck Surg 1990;102: 382-390. (Pubitemid 20152734)
6. Drovdlic CM, Myers EN, Peters JA, Baysal BE, Brackmann DE, Slattery WH 3rd, Rubinstein WS: Proportion of heritable paraganglioma cases and associated clinical characteristics. Laryngoscope 2001;111:1822-1827. (Pubitemid 32946461)
7. Maher ER, Eng C: The pressure rises: update on the genetics of pheochromocytoma. Hum Mol Genet 2002;11:2347-2354. (Pubitemid 35174697)
8. Bausch B, Borozdin W, Mautner VF, European- American Phaeochromocytoma Registry Study Group: Germline NF1 mutational spectra and loss- of- heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1. J Clin Endocrinol Metab 2007;92:2784-2792. (Pubitemid 47037390)
9. Amar L, Servais A, Gimenez- Roquelpo AP, Zinzindohoue F, Chatellier G, Plouin PF: Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. J Clin Endocrinol Metab 2005;90:2110-2116. (Pubitemid 40586247)
10. Khorram- Manesh A, Ahlman H, Nilsson O, et al: Long term outcome of a large series of patients surgically treated for pheochromocytoma. J Intern Med 2005; 258:55-66. (Pubitemid 40904933)
11. Goldstein RE, ONeill JA Jr, Holcomb GW 3rd, et al: Clinical experience over 48 years with pheochromocytoma. Ann Sug 1999;229:755-764.
12. Schlisio S, Kenchappa RS, Vredeveld LC, et al: The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. Genes Dev 2008;22:884-893. (Pubitemid 351482842)
13. Yeh IT, Lenci RE, Qin Y, et al: A germline mutation of the KIF1B beta gene on 1p36 in a family with neural and nonneural tumors. Hum Genet 2008;124: 279-285.
14. Baysal BE, Ferrell RE, Willett- Brozick JE, et al: Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000;287:848-851. (Pubitemid 30084326)
15. Heutink P, van der Mey AG, Sandkuijl LA, et al: A gene subject to genomic imprinting and responsible for hereditary paragangliomas maps to chromosome 11q23- qter. Hum Mol Genet 1992; 1:7-10.
16. Heutink P, van Schothorst EM, van der Mey AG, et al: Further localization of the gene for hereditary paragangliomas and evidence for linkage in unrelated families. Eur J Hum Genet 1994;2: 148-158. (Pubitemid 24305442)
17. Baysal BE, Farr JE, Rubinstein WS, et al. Fine mapping of an imprinted gene for familial nonchromaffin paragangliomas, on chromosome 11q23. Am J Hum Genet 1997;60:121-132. (Pubitemid 26427786)
18. Milunsky J, DeStefano AL, Huang XL, et al: Familial paragangliomas: linkage to chromosome 11q23 and clinical implications. Am J Med Genet 1997;72:66-70. (Pubitemid 27377120)
19. Mariman EC, van Beersum SE, Cremers CW, van Baars FM, Ropers HH: Analysis of a second family with hereditary nonchromaffin paragangliomas locates the underlying gene at the proximal region of chromosome 11q. Hum Genet 1993; 91:357-361. (Pubitemid 23177491)
20. Mariman EC, van Beersum SE, Cremers CW, Struycken PM, Ropers HH: Fine mapping of a putatively imprinted gene for familial non- chromaffin paragangliomas to chromosome 11q13.1: evidence for genetic heterogeneity. Hum Genet 1995;95:56-62.
21. Niemann S, Steinberger D, Müller U: PGL3, a third, not maternally imprinted locus in autosomal dominant paraganglioma. Neurogenetics 1999;2:167-170. (Pubitemid 29484576)
22. Niemann S, Becker- Follmann J, Mürnberg G, et al: Assignment of PGL3 to chromosome 1 (q21- q23) in a family with autosomal dominant nonchromaffin paraganglioma. Am J Med Genet 2001;98:32-36. (Pubitemid 32041848)
23. Sato T, Saito H, Yoshinaga K, Shibota Y, Sasano N: Concurrence of carotid body tumor and pheochromocytoma. Cancer 1974;34:1787-1795.
24. Niemann S, Müller U: Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 2000;26: 268-270.
25. Astuti D, Latif F, Dallol A, et al: Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 2001;69:49-54. (Pubitemid 32614017)
26. Hao HX, Khalimonchuk O, Schraders M, Dephoure N, Bayley JP, Kunst H, Devilee P, Cremers CW, Schiffman JD, Bentz BG, Gygi SP, Winge DR, Kremer H, Rutter J: SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 2009;28:1139-1142.
27. Baysal BE, Ferrell RE, Willett- Brozick JE, et al: Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000;287:848-851. (Pubitemid 30084326)
28. Van Baars, FM, Cremers CWRJ, van den Broek P, Veldman JE: Familial nonchromaffinic paragangliomas (glomus tumors): clinical and genetic aspects. Acta Otolaryng 1981;91:589-593. (Pubitemid 11064273)
29. Pasini B, Stratakis CA: SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma- paraganglioma syndromes. J Intern Med 2009;266:19-42.
30. Burnichon N, Rohmer V, Amar L, Herman P, et al: PGL.NET network. J Clin Endocrinol Metab 2009;94:2817-2827.
31. Ricketts CJ, Forman JR, Rattenberry E, et al: Tumor risks and genotypephenotype- proteotype analysis in 358 patients with germline mutations in SDHB and SDHD. Hum Mutat 2010;31:41-51.
32. Neumann HP, Eng C. The approach to the patient with paraganglioma. J Clin Endocrinol Metab 2009;94:2677-2683.
33. Benn DE, Richardson AL, Marsh DJ, Robinson BG: Genetic testing in pheochromocytoma- and paragangliomaassociated syndromes. Ann NY Acad Sci 2006;1073:104-111. (Pubitemid 44912003)
34. Erlic Z, Neumann HP: Diagnosing patients with hereditary paraganglial tumours. Lancet Oncol 2009;10:741.
35. Cascón A, López- Jiménez E, Landa I, Leskelä S, Leandro- García LJ, Maliszewska A, Letón R, de la Vega L, García- Barcina MJ, Sanabria C, Alvarez- EscolÁ C, Rodríguez- Antona C, Robledo M: Rationalization of genetic testing in patients with apparently sporadic pheochromocytoma/ paraganglioma. Horm Metab Res 2009;41:672-675.
36. Bertherat J, Gimenez- Roqueplo AP: New insights in the genetics of adrenocortical tumors, pheochromocytomas and paragangliomas. Horm Metab Res 2005;37: 384-390. (Pubitemid 41008774)
37. Burnichon N, Brière JJ, Libé R, Vescovo L, Rivière J, Tissier F, Jouanno E, Jeunemaitre X, Bénit P, Tzagoloff A, Rustin P, Bertherat J, Favier J, Gimenez- Roqueplo AP: SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet 2010;19:3011-3020.
38. Qin Y, Yao L, King EE, Buddavarapu K, Lenci RE, Chocron ES, Lechleiter JD, Sass M, Aronin N, Schiavi F, Boaretto F, Opocher G, Toledo RA, Toledo SP, Stiles C, Aguiar RC, Dahia PL: Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nat Genet 2010;42:229-233.
39. Yao L, Schiavi F, Cascon A, Qin Y, Inglada-Pérez L, King EE, Toledo RA, Ercolino T, Rapizzi E, Ricketts CJ, Mori L, Giacchè M, Mendola A, Taschin E, Boaretto F, Loli P, Iacobone M, Rossi GP, Biondi B, Lima-Junior JV, Kater CE, Bex M, Vikkula M, Grossman AB, Gruber SB, Barontini M, Persu A, Castellano M, Toledo SP, Maher ER, Mannelli M, Opocher G, Robledo M, Dahia PL: Spectrum and prevalence of FP/ TMEM127 gene mutations in pheochromocytomas and paragangliomas. JAMA 2010;304:2611-2619.